ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,433Medicare Part D Prescriptions Filled, Including Refills

Rank: 131 out of 761

$566K Total Retail Price of All Prescriptions

Rank: 83 out of 761

477 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 477 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

10% of this provider’s 477 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 8,179 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 484 413 1 3
LISINOPRIL 463 420 2 1
AMLODIPINE BESYLATE 305 264 3 6
ATORVASTATIN CALCIUM 248 236 4 12
LOSARTAN POTASSIUM 238 220 5 13
METOPROLOL SUCCINATE 235 208 6 16
SIMVASTATIN 232 219 7 2
POTASSIUM CHLORIDE 232 195 7 18
FUROSEMIDE 231 212 9 7
OMEPRAZOLE 223 174 10 4
CRESTOR 204 189 11 36
CITALOPRAM HBR 201 194 12 19
PRAVASTATIN SODIUM 181 157 13 20
HYDROCODONE-ACETAMINOPHEN 173 152 S3 14 5
FLUTICASONE PROPIONATE 162 150 15 29
ZOLPIDEM TARTRATE 156 137 16 22
ALENDRONATE SODIUM 134 134 17 21
CHLORTHALIDONE 128 100 18 89
WARFARIN SODIUM 125 118 19 9
GABAPENTIN 115 104 20 15
METOPROLOL TARTRATE 114 114 21 14
PREDNISONE 107 100 22 30
ATENOLOL 103 94 23 8
METFORMIN HCL 92 90 24 10
HYDROCHLOROTHIAZIDE 92 81 24 11
ALLOPURINOL 92 66 24 28
CARVEDILOL 84 82 27 26
NIASPAN 81 67 28 159
CLOPIDOGREL 78 73 29 66
SERTRALINE HCL 75 71 30 25
PLAVIX 69 64 31 119
ADVAIR DISKUS 67 57 32 37
KLOR-CON 10 67 61 32 74
ISOSORBIDE MONONITRATE ER 66 54 34 72
CLONIDINE HCL 66 46 34 69
ESCITALOPRAM OXALATE 62 38 36 102
RANITIDINE HCL 61 37 37 52
CIPROFLOXACIN HCL 59 56 38 63
CYMBALTA 59 49 38 53
SPIRIVA 58 55 40 56
GLIMEPIRIDE 57 53 41 48
TRIAMTERENE-HCTZ 54 40 42 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 51 42 35
TRAMADOL HCL 53 51 44 34
SINGULAIR 53 39 44 138
DIGOXIN 52 52 46 43
OXYCODONE HCL 52 26 S2 46 24
DONEPEZIL HCL 51 51 48 33
PROAIR HFA 51 46 48 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.